Search results for: 'real world evidence market'

The evolving IT landscape has played a transformative role in the field of life sciences, enabling a reliance on real-world evidence (RWE) solutions. With growing competition and the demand for precision in decision-making, pharmaceutical companies, healthcare providers, and technology organizations have realized the need for real-world data (RWD) ...

Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...

05 Feb 2021  |  North America  |  Market Research

Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

Infographics

×

The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

The global healthcare RTLS market is evolving beyond traditional asset tracking toward intelligent location platforms that enable real-time visibility, workflow optimization, and operational decision-making across healthcare environments. As healthcare providers continue investing in digital transformation, RTLS is increasingly being deployed as an...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...

Continuous health monitoring technologies are playing an instrumental role in healthcare by enabling real-time monitoring of vital signs, including heart rate, respiration rate, and blood pressure, thereby enhancing early disease detection and chronic disease management.The growing burden of chronic diseases, an aging population, and a shift toward...

30 Jun 2023  |  Global  |  Technology Research

Neonatal Monitoring: Technology Innovation and Growth Opportunities

AI-enabled Noninvasive Monitoring that Offers Real-time Feedback and Intelligent Decision-making Drives Transformational Growth.

Infographics

×

Neonatal monitoring medical technologies monitor newborn babies’ health and vital signs in the first few days or weeks of their life. These technologies are used in neonatal intensive care units (NICUs) and other hospital settings or at home. Some commonly used neonatal monitoring devices include electrocardiography (ECG) monitors, pulse oximetry m...

The World Protein Array Market deliverable of the Proteomics Market Service provides an in depth analysis of this emerging market. In addition to analysis at the segment level, we provide a penetration based forecast model derived from drug discovery R&D expenditures. Also included are market trends, challenges, opportunities and strategic conclu...